About BIOVOX

The healthcare industry, while essential for human well-being, has a significant carbon footprint. Single-use medical products, made primarily from fossil-based plastics, contribute significantly to this environmental impact. BIOVOX, a German startup, is on a mission to change this by developing sustainable, bio-based alternatives for these products.

Tackling the Challenge of Sustainable Healthcare Plastics

BIOVOX is addressing the pressing issue of plastic waste in healthcare by producing the world’s first sustainable medical-grade bioplastics. These materials offer a greener alternative to traditional fossil-based plastics, reducing carbon emissions and promoting a more sustainable healthcare system.

Meet the Team Behind BIOVOX

Founded in 2021 by Julian Lotz, Vinzenz Nienhaus, and Carmen Rommel, BIOVOX has assembled a team of experts dedicated to developing innovative and sustainable solutions. Their expertise in bioplastics, medical technology, and regulatory affairs has been instrumental in driving the company’s success.

BIOVOX’s Innovative Bioplastic Solutions

BIOVOX’s bioplastics are designed to meet the highest regulatory standards, ensuring safety and efficacy in medical applications. These materials offer a range of benefits, including:

• Reduced carbon footprint: BIOVOX’s bioplastics have a significantly lower carbon footprint compared to traditional plastics.
• Biocompatibility: The materials are safe for use in medical applications and have been tested for biocompatibility.
• Versatility: BIOVOX’s bioplastics can be used in a variety of medical products, including consumables, disposables, packaging, and surgical instruments.

Market Impact and Customer Adoption

BIOVOX’s innovative bioplastics have attracted significant interest from the healthcare industry. Over 50 customers, including leading medical device companies, are working with BIOVOX to develop sustainable healthcare solutions. This growing customer base demonstrates the market demand for greener alternatives to traditional plastics.

Funding and Future Growth

BIOVOX recently secured €2.2 million in seed funding, led by High-Tech Gründerfonds. This investment will enable the company to accelerate the development of its bioplastic portfolio, scale operations, and expand its market reach.

Dr.-Ing. Julian Lotz, CEO of BIOVOX, expressed his enthusiasm about the funding: “With this support, we will be able to scale our organization and meet the growing demand for sustainable healthcare plastics. Our goal is to create a more environmentally friendly future for the healthcare industry.”

BIOVOX is at the forefront of the sustainable healthcare revolution. By developing innovative bioplastic solutions, the company is helping to reduce the environmental impact of the healthcare industry while maintaining high standards of safety and quality. As the demand for sustainable products continues to grow, BIOVOX is well-positioned to become a leading player in this market.